Femi Olawale
About
Femi Olawale is a scholar working on Molecular Biology, Computational Theory and Mathematics and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Femi Olawale has authored 34 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Femi Olawale's work include Computational Drug Discovery Methods (10 papers), Natural Antidiabetic Agents Studies (7 papers) and Natural product bioactivities and synthesis (5 papers). Femi Olawale is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Natural Antidiabetic Agents Studies (7 papers) and Natural product bioactivities and synthesis (5 papers). Femi Olawale collaborates with scholars based in South Africa, Nigeria and Egypt. Femi Olawale's co-authors include Opeyemi Iwaloye, Olusola Olalekan Elekofehinti, Kolawole A. Olofinsan, Mario Ariatti, Moganavelli Singh, Ademola Emmanuel Adetunji, Chijioke Olisah, Adeyemi O. Aremu, Sunday Amos Onikanni and Sergey Shityakov and has published in prestigious journals such as Biomedicine & Pharmacotherapy, Frontiers in Oncology and Nanomaterials.
In The Last Decade
Femi Olawale
34 papers receiving 454 citations
Peers
Femi Olawale
Laura Machín Cuba
Reza Entezari Heravi Iran
Rana M. Merghany Egypt
Rebamang A. Mosa South Africa
Muhammad Umair Arshad Pakistan
Langeswaran Kulanthaivel India
Werner Cordier South Africa
Abul Bashar Ripon Khalipha Bangladesh
Xu-Dong Hou China
Matthew Iyobhebhe Nigeria
Citations per year, relative to Femi Olawale Femi Olawale (= 1×)
peers
Laura Machín
Countries citing papers authored by Femi Olawale
Since
Specialization
Citations
This map shows the geographic impact of Femi Olawale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Femi Olawale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Femi Olawale more than expected).
Fields of papers citing papers by Femi Olawale
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Femi Olawale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Femi Olawale. The network helps show where Femi Olawale may publish in the future.
Co-authorship network of co-authors of Femi Olawale
This figure shows the co-authorship network connecting the top 25 collaborators of Femi Olawale. A scholar is included among the top collaborators of Femi Olawale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Femi Olawale. Femi Olawale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kuo, Yu-Cheng, Bashir Lawal, Adewale Oluwaseun Fadaka, et al.. (2024). Evaluation of terpenes rich Hura crepitans extract on glucose regulation and diabetic complications in STZ-induced diabetic rats. Biomedicine & Pharmacotherapy. 179. 117308–117308.
2.
Ogunyemi, Oludare M., Gideon Ampoma Gyebi, Femi Olawale, et al.. (2024). Identification of promising dipeptidyl peptidase-4 and protein tyrosine phosphatase 1B inhibitors from selected terpenoids through molecular modeling. Bioinformatics Advances. 5(1). vbae205–vbae205.
3.
Lamichhane, Gopal, Femi Olawale, Jing Liu, et al.. (2024). Curcumin Mitigates Gut Dysbiosis and Enhances Gut Barrier Function to Alleviate Metabolic Dysfunction in Obese, Aged Mice. Biology. 13(12). 955–955.
4.
Iwaloye, Opeyemi, et al.. (2023). Biological activities of African medicinal plants in the treatment of erectile dysfunction: a mechanistic perspective. Hormone Molecular Biology and Clinical Investigation. 44(4). 357–370.
5.
Lawal, Bashir, Sunday Amos Onikanni, Femi Olawale, et al.. (2023). Apigetrin-enriched Pulmeria alba extract prevents assault of STZ on pancreatic β-cells and neuronal oxidative stress with concomitant attenuation of tissue damage and suppression of inflammation in the brain of diabetic rats. Biomedicine & Pharmacotherapy. 162. 114582–114582.
6.
Umar, Haruna Isiyaku, et al.. (2023). Identification of a 1, 8-naphthyridine-containing compound endowed with the inhibition of p53-MDM2/X interaction signaling: a computational perspective. Molecular Diversity. 28(3). 1109–1127.
7.
Lawal, Bashir, Yu-Cheng Kuo, Sunday Amos Onikanni, et al.. (2023). Computational identification of novel signature of T2DM-induced nephropathy and therapeutic bioactive compounds from Azanza garckeana.. PubMed. 15(7). 4504–4520.
8.
Olawale, Femi, et al.. (2023). Nutraceutical evaluation of Evolvulus alsinoides (L.,) L. a browse species collected from the wild around Selwane Village, Limpopo Province, South Africa. South African Journal of Botany. 157. 243–250.
9.
Olawale, Femi, Mario Ariatti, & Moganavelli Singh. (2022). Ocimum tenuiflorum L mediated green synthesis of silver and selenium nanoparticles: antioxidant activity, cytotoxicity and density functional theory studies. Advances in Natural Sciences Nanoscience and Nanotechnology. 13(1). 15015–15015.
10.
Olawale, Femi, et al.. (2022). Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer. Frontiers in Oncology. 12. 908487–908487.
11.
Lawal, Bashir, Sunday Amos Onikanni, Femi Olawale, et al.. (2022). Attenuation of hyperglycemia-associated dyslipidemic, oxidative, cognitive, and inflammatory crises via modulation of neuronal ChEs/NF-κB/COX-2/NOx, and hepatorenal functional deficits by the Tridax procumbens extract. Biomedicine & Pharmacotherapy. 158. 114114–114114.
12.
Olawale, Femi, Opeyemi Iwaloye, Kolawole A. Olofinsan, et al.. (2022). Homology modelling, vHTS, pharmacophore, molecular docking and molecular dynamics studies for the identification of natural compound-derived inhibitor of MRP3 in acute leukaemia treatment. Chemical Papers. 76(6). 3729–3757.
13.
Iwaloye, Opeyemi, et al.. (2022). Fragment-Based Drug Design, 2D-QSAR and DFT Calculation: Scaffoldsof 1, 2, 4, triazolo [1, 5-a] pyrimidin-7-amines as Potential Inhibitors ofPlasmodium falciparum Dihydroorotate Dehydrogenase. Letters in Drug Design & Discovery. 20(3). 317–334.
14.
Lawal, Bashir, Sunday Amos Onikanni, Femi Olawale, et al.. (2022). Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents. Biomedicine & Pharmacotherapy. 152. 113196–113196.
15.
Olawale, Femi, et al.. (2022). The therapeutic value of alstonine: An updated review. South African Journal of Botany. 152. 288–295.
16.
Olawale, Femi, et al.. (2021). Long Term Effects of Streptozotocin Induced Diabetes Mellitus on Hepatic, Nephrotic and Cardiac Physiology of Female Wistar Rats. 17(1). 71–80.
17.
Elekofehinti, Olusola Olalekan, et al.. (2021). Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design. In Silico Pharmacology. 9(1). 47–47.
18.
Olawale, Femi, et al.. (2021). Screening of compounds from Nigerian antidiabetic plants as protein tyrosine phosphatase 1B inhibitor. Computational Toxicology. 21. 100200–100200.
19.
Olawale, Femi, et al.. (2021). A Multi-target Approach for the Discovery of Anti Breast Cancer Agents from Plants Secondary Metabolites. Letters in Drug Design & Discovery. 18(10). 1009–1023.
20.
Olawale, Femi, et al.. (2020). Long-Term Hyperglycemia Impairs Hormonal Balance and Induces Oxidative Damage in Ovaries of Streptozotocin-Induced Diabetic Wistar Rat.. Nigerian Journal of Physiological Sciences. 35(1). 46–51.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Laura Machín Breakdown of academic impact, for papers by Reza Entezari Heravi Breakdown of academic impact, for papers by Rana M. Merghany Breakdown of academic impact, for papers by Rebamang A. Mosa Breakdown of academic impact, for papers by Muhammad Umair Arshad Breakdown of academic impact, for papers by Langeswaran Kulanthaivel Breakdown of academic impact, for papers by Werner Cordier Breakdown of academic impact, for papers by Abul Bashar Ripon Khalipha Breakdown of academic impact, for papers by Xu-Dong Hou Breakdown of academic impact, for papers by Matthew Iyobhebhe